| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.087 | 0.1 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.1 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.052 | 0.1 |